Advances in sleep medicine, explained by the clinic's team.
Sleep Congress 2026 (SFRMS) in Lyon
Lyon — 40th SFRMS edition
The annual gathering of sleep specialists: healthcare professionals, researchers and patient associations. La Clinique du Sommeil will attend this landmark 40th edition of the SFRMS congress in Lyon.
September 10, 2026
A recent study reveals that nearly 25% of patients with Parkinson's disease suffer from Restless Legs Syndrome, often undiagnosed. This syndrome is linked to poor sleep quality and an increase in dopaminergic treatments, highlighting the importance of systematic screening.
A recent study highlights the association between obstructive sleep apnea and high blood pressure. While this relationship is recognized, the effectiveness of continuous positive airway pressure treatment in reducing blood pressure remains to be confirmed. Practical tools are emerging to identify at-risk patients.
September 7, 2026
A study examined the link between the endothelial activation and stress index (EASIX) and the severity of obstructive sleep apnea (OSA). The results show that higher levels of EASIX are associated with an increased risk of mortality, both overall and cardiovascular, in individuals suffering from OSA.
Restless Legs Syndrome (RLS) is increasingly recognized as a condition involving dysfunctions of the autonomic nervous system. A systematic review examined how this can affect various aspects of health, including cardiovascular and gastrointestinal, thereby impacting the quality of life of patients.
September 3, 2026
A recent study examines the effect of expiratory pressure relief (EPA) algorithms on the effectiveness of CPAP devices in patients with severe obstructive sleep apnea. The results show that EPA may compromise upper airway patency and require higher CPAP levels.
A systematic review examines the use of audio signals to detect obstructive sleep apnea (OSA). Although polysomnography is the standard, studies show that artificial intelligence could provide an accurate alternative for identifying the risks of moderate to severe OSA.
September 1, 2026
General practitioner Dr Stéphanie Herzog has joined the medical team of the Yutz Sleep Clinic. She handles consultations and patient follow-up, and is currently completing a University Diploma in sleep medicine.
August 31, 2026
A recent study examined the relationship between insomnia and chronic pain. The results show that individuals suffering from insomnia have an increased risk of developing pain, while the reverse is not observed. This underscores the importance of treating insomnia to improve pain management.
A study examined the link between levels of sLRP-1, a protein involved in inflammation and metabolism, and obstructive sleep apnea (OSA) in snoring adults. The results show that lower levels of sLRP-1 are associated with an increased risk of OSA, but further validations are needed before any clinical application.
August 27, 2026
A recent study examined the link between physical activity and insomnia symptoms. The results show that moderate physical activity is associated with a reduced risk of insomnia, while work-related physical activity may increase it. These findings highlight the importance of the nature of physical activity on sleep health.
A study compared the effectiveness of cognitive behavioral therapy for insomnia (CBT-I) and bright light therapy (BLT) in women receiving chemotherapy for breast cancer. The results show that CBT-I improves insomnia symptoms, but not BLT.
August 24, 2026
A recent study examines the association between cannabis use and signs of respiratory disorders during sleep among American adults. The results show a correlation, but causality remains to be established. Further research is needed to better understand this relationship.
A study explored the link between sleep disorders, mild cognitive decline, and frailty in adults with chronic pain. The results show that these disorders are associated with greater frailty, which could influence patient assessments and follow-ups.
A study evaluated the orexin receptor 2 agonist, alixorexton, for type 1 narcolepsy. This treatment showed significant improvements in alertness and cataplexy. Side effects were generally tolerable, paving the way for further studies.
A recent study suggests that sleeping too little or too much may be linked to faster body aging. Researchers observed that individuals sleeping between 6.4 and 7.8 hours per day showed the lowest levels of aging. Various health issues are also associated with inappropriate sleep durations.
August 22, 2026
A recent study showed that the combination of virtual reality and biofeedback improves sleep quality and daytime function in patients suffering from chronic insomnia. The results indicate a reduction in nighttime awakenings and an improvement in daytime fatigue, with no significant adverse effects.
August 7, 2026
A new portable patch could help achieve REM sleep more quickly and stay in it longer, without the use of medication or surgery. A study showed a reduction of 43 minutes in the time needed to reach this sleep phase.
July 31, 2026
A study reveals that maintaining a regular daily routine can help reduce pain and depression, particularly in older adults suffering from insomnia. Consistent schedules for waking, eating, socializing, and sleeping are associated with better well-being, regardless of sleep quality.
A recent study revealed that a gene linked to the brain's nighttime cleaning system may influence the impact of poor sleep on brain changes associated with Alzheimer's disease. This paves the way for more personalized prevention strategies.
July 20, 2026
A recent study revealed that immune cells in the brain, called microglia, may be responsible for sleep loss in people with Alzheimer’s disease. By temporarily modifying these cells, researchers observed an improvement in sleep without affecting amyloid plaques.
July 5, 2026
Researchers have identified a brain circuit that connects deep sleep to the release of growth hormone. This discovery explains how sleep, muscle growth, fat metabolism, and brain function influence each other. It could pave the way for new therapies for sleep disorders and certain diseases.
May 15, 2026
The SynAIRgy trial (phase 3, 646 patients) shows that a daily tablet significantly reduces apnoeas by strengthening the tone of the upper-airway muscles. A promising alternative to CPAP machines for patients who cannot tolerate them.
January 7, 2026
Stanford researchers have developed SleepFM, an AI able to analyse polysomnography data to predict the risk of cancers, heart disease, mental disorders and many other conditions — sometimes years before diagnosis.
